Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 86 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

 
Table of Contents
LETTER TO THE EDITOR
Year : 2020  |  Volume : 24  |  Issue : 6  |  Page : 554-555

Is Paget Disease of Bone a Predominant Disease of South India? Clinical Characteristics, Therapeutic Outcome and Follow Up of 66 Patients from Tamil Nadu and Brief Review of Epidemiology


1 Department of Endocrinology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai, Tamil Nadu, India
2 Department of Endocrinology, Mazumdar Shah Medical Centre, Bommasandra, Bengaluru, Karnataka, India
3 Department of Endocrinology, Kamakshi Memorial Hospital, Chennai, Tamil Nadu, India
4 Department of Endocrine Surgery, Madras Medical College, Chennai, Tamil Nadu, India

Date of Submission13-Oct-2020
Date of Acceptance19-Oct-2020
Date of Web Publication12-Jan-2021

Correspondence Address:
Shriraam Mahadevan
Professor and Head, Department of Endocrinology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai - 600 116, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijem.IJEM_713_20

Rights and Permissions

How to cite this article:
Asirvatham AR, Kannan S, Mahadevan S, Balachandran K, Sampathkumar G, Sadacharan D, Balasubramanian SK. Is Paget Disease of Bone a Predominant Disease of South India? Clinical Characteristics, Therapeutic Outcome and Follow Up of 66 Patients from Tamil Nadu and Brief Review of Epidemiology. Indian J Endocr Metab 2020;24:554-5

How to cite this URL:
Asirvatham AR, Kannan S, Mahadevan S, Balachandran K, Sampathkumar G, Sadacharan D, Balasubramanian SK. Is Paget Disease of Bone a Predominant Disease of South India? Clinical Characteristics, Therapeutic Outcome and Follow Up of 66 Patients from Tamil Nadu and Brief Review of Epidemiology. Indian J Endocr Metab [serial online] 2020 [cited 2021 Jun 23];24:554-5. Available from: https://www.ijem.in/text.asp?2020/24/6/554/306758



Sir,

Thank you for showing interest in our recent article on Paget disease of bone (PDB). We have addressed your queries below.

This disease appears to be more common in south India based on the number of cases and case series reported in the Indian literature so far (Ref: 8,9,11,17-64 in the article). Prevalence of any disease is generally considered to be overrated when published from an institute due to the possible referral bias. The cases reported in this paper were seen in private outpatient clinics of mainly two authors and moreover two major case series from India are also from Vellore (near Chennai, South India). In addition, as mentioned in our article, the series from North had pooled patients from all over India and not exclusively from that region. Thus we strongly feel that this disease probably has some predominance in south India. However, this needs more exploration with prospective collaborative studies from all zones. Bisphosphonates especially zoledronate has been shown to be very efficacious in PDB remission. This study reiterates the same observation. The patients included in this study had atleast 1 year follow up following zoledronate. The last patient was followed up in January 2020 and hence the time period was mentioned as until 2020. All the series from the west (17 cases), north (21 cases - out of which only 4 were from Chandigarh) and south (51 cases) were published in 2006, but the number of cases from south was strikingly more than the other zones. In 2018, another large series from Vellore (south) was published that excluded the cases from their previous series but there were no major case series from any other zone since 2006 other than isolated case reports. In our paper, we had mentioned as the largest cohort that has ever been studied in India since we had included 66 patients. FDG PET scan was not done in all patients as it is not required for diagnosis. But out of 66 patients in our series, 6% of patients underwent FDG PET scan for their symptoms during work up elsewhere and were incidentally diagnosed to have PDB and referred for management. Remission was defined as clinical improvement and normalisation of alkaline phosphatase which occurred in 61 out of 66 patients in 1 year and hence the remission percentage was calculated as 92.4%.

We hope that your questions have been satisfactorily answered in our reply. We thank you again for giving us the opportunity.

Dr. Shriraam Mahadevan

Professor & Head, Department of Endocrinology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai – 600116, Tamil Nadu, India

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.






 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed334    
    Printed4    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal